A Phase I, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Tolerance of Oil Palm Phenolics (OPP) in Healthy Volunteers

A Phase I, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Tolerance of Oil Palm Phenolics (OPP) in Healthy Volunteers

Background and aim: Oil palm aqueous by-products rich in phenolic content are known as oil palm phenolics (OPP), and pre-clinical research has shown that OPP has great potential to be further developed as an anti-hyperlipidemic agent. Hence, in order to introduce OPP into market, its safety profile...

Full description

Bibliographic Details
Main Authors: Nur Balqis Muhammad Ismail Tadj, Nurul ‘Izzah Ibrahim, Qodriyah Haji Mohd Saad, Tg Mohd Ikhwan Tg Abu Bakar Sidik, Soon-Sen Leow, Syed Fairus, Isa Naina Mohamed
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Pharmacology
Subjects:
oil palm phenolics
clinical trial (CT)
antihyperlipidemia
antioxidant
natural products
safety and toxicology
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.893171/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.893171/full

Similar Items